[ Price : $8.95]
Members of FDAs Respiratory Therapy Devices Panel vote 6-1 to recommend approval with conditions of Asthmatx Alair System bronchia...[ Price : $8.95]
Genta says the AGENDA Phase 3 trial of Genasense failed to meet a co-primary endpoint and secondary endpoints.[ Price : $8.95]
Novartis says it has almost tripled H1N1 vaccine yield after moving to a newer seed virus and production has been accelerating as ...[ Price : $8.95]
FDA Webview editor Jim Dickinson reviews FDAs crushing defeat of TMJ Implants Inc. in the Tenth Circuit Court of Appeals and sees ...[ Price : $8.95]
AstraZeneca withdraws its NDA Zactima (vandetanib) 100mg in combination with chemotherapy that sought approval for use in patients...[ Price : $8.95]
Qualitest Pharmaceuticals recalls all Accusure Insulin Syringes that have been distributed nationwide between 2002 and 2009.[ Price : $8.95]
Members of FDAs Anti-infective Drugs Advisory Committee say it is likely that Human Genome Sciences ABthrax may help treat people ...[ Price : $8.95]
FDA Webview posts to our site the latest FDA inspection documents we have received pursuant to our FOIA requests, for: Abbott Labo...